Norovirus VLP intramuscular vaccine: Phase I started

Ligocyte began a double-blind, placebo-controlled, dose-escalation, U.S. Phase I trial to evaluate 2 doses of 5, 15, 50 and 150 µg Norovirus VLP intramuscular vaccine given 28 days apart in 98 healthy...